fda warning peptides bpc-157 BPC 157 Banned: Key Facts on the Latest Decision FDA's Overreach on Compounded Peptides

American Journal of Clinical Dermatology volume 15, pages217230 (2014) 6

This provides an important tool for research into aging-related neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, and offers experimental evidence for intervention strategies in neuronal aging

It helps the bodys ability to produce red blood cells, resulting in increased energy, improved cognitive function, and balance

Only three pilot studies have examined BPC-157 in humans, including its use for intraarticular knee pain, interstitial cystitis, and intravenous safety/pharmacokinetics

Since a patients stem cells make up the BMAC, there is no real risk of rejection